What we do
Our mission is to develop, optimise and distribute innovative pharmaceutical products that offer a unique solution for unmet patient needs across all major global markets.
We take the Active Pharmaceutical Ingredient (API) of medicines already marketed as tablets and capsules and develop an equivalent product in a stable, ready-to-use liquid form.
Our liquid products offer practical, daily ease of use and convenience for the many patients who are unable to swallow conventional tablets and capsules or find swallowing them difficult. Our products are of particular value in young children, and they help ensure regular, consistent dosing and allow for precise dose adjustment in response to their increasing body weight. Green Park products will also offer hitherto unavailable convenience and practicality in meeting the needs of adults experiencing difficulty in swallowing, including those suffering from stroke, head injury, dementia and some forms of cancer.
